Antigen	O
specificity	O
determines	O
anti-red	B:C0003241
blood	I:C0003241
cell	I:C0003241
IgG	I:C0003241
-	I:C0003241
Fc	I:C0003241
alloantibody	I:C0003241
glycosylation	O
and	O
thereby	O
severity	O
of	O
haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
.	O

Antigen	O
specificity	O
determines	O
anti-red	O
blood	I:C0003241
cell	I:C0003241
IgG	I:C0003241
-	I:C0003241
Fc	I:C0003241
alloantibody	I:C0003241
glycosylation	O
and	O
thereby	O
severity	O
of	O
haemolytic	B:C0014761
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
.	O

Haemolytic	B:C0014761
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
(	O
Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
)	O
is	O
a	O
severe	O
disease	O
in	O
which	O
fetal	O
red	O
blood	I:C0014792
cells	I:C0014792
(	O
red	O
blood	I:C0014792
cells	I:C0014792
)	O
are	O
destroyed	O
by	O
maternal	O
anti-RBC	I:C0729663
IgG	I:C0729663
alloantibodies	I:C0729663
.	O

Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
(	O
Haemolytic	B:C0014761
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
)	O
is	O
a	O
severe	O
disease	O
in	O
which	O
fetal	O
red	O
blood	I:C0014792
cells	I:C0014792
(	O
red	O
blood	I:C0014792
cells	I:C0014792
)	O
are	O
destroyed	O
by	O
maternal	O
anti-RBC	I:C0729663
IgG	I:C0729663
alloantibodies	I:C0729663
.	O

Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
(	O
Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
)	O
is	O
a	O
severe	O
disease	B:C0012634
in	O
which	O
fetal	O
red	O
blood	I:C0014792
cells	I:C0014792
(	O
red	O
blood	I:C0014792
cells	I:C0014792
)	O
are	O
destroyed	O
by	O
maternal	O
anti-RBC	I:C0729663
IgG	I:C0729663
alloantibodies	I:C0729663
.	O

Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
(	O
Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
)	O
is	O
a	O
severe	O
disease	O
in	O
which	O
fetal	B:C0015965
red	O
blood	I:C0014792
cells	I:C0014792
(	O
red	O
blood	I:C0014792
cells	I:C0014792
)	O
are	O
destroyed	O
by	O
maternal	O
anti-RBC	I:C0729663
IgG	I:C0729663
alloantibodies	I:C0729663
.	O

Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
(	O
Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
)	O
is	O
a	O
severe	O
disease	O
in	O
which	O
fetal	O
red	B:C0014792
blood	I:C0014792
cells	I:C0014792
(	O
red	O
blood	I:C0014792
cells	I:C0014792
)	O
are	O
destroyed	O
by	O
maternal	O
anti-RBC	I:C0729663
IgG	I:C0729663
alloantibodies	I:C0729663
.	O

Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
(	O
Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
)	O
is	O
a	O
severe	O
disease	O
in	O
which	O
fetal	O
red	O
blood	I:C0014792
cells	I:C0014792
(	O
red	B:C0014792
blood	I:C0014792
cells	I:C0014792
)	O
are	O
destroyed	O
by	O
maternal	O
anti-RBC	I:C0729663
IgG	I:C0729663
alloantibodies	I:C0729663
.	O

Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
(	O
Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
)	O
is	O
a	O
severe	O
disease	O
in	O
which	O
fetal	O
red	O
blood	I:C0014792
cells	I:C0014792
(	O
red	O
blood	I:C0014792
cells	I:C0014792
)	O
are	O
destroyed	O
by	O
maternal	B:C0729663
anti-RBC	I:C0729663
IgG	I:C0729663
alloantibodies	I:C0729663
.	O

Haemolytic	B:C0014761
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
is	O
most	O
often	O
caused	O
by	O
anti-D	O
but	O
may	O
also	O
occur	O
due	O
to	O
anti-K	O
,	O
-c	O
-	O
or	O
-	O
E	I:C0947659
.	O

Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
is	O
most	O
often	O
caused	O
by	O
anti-D	B:C0140430
but	O
may	O
also	O
occur	O
due	O
to	O
anti-K	O
,	O
-c	O
-	O
or	O
-	O
E	I:C0947659
.	O

Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
is	O
most	O
often	O
caused	O
by	O
anti-D	O
but	O
may	O
also	O
occur	O
due	O
to	O
anti-K	B:C0313239
,	O
-c	O
-	O
or	O
-	O
E	I:C0947659
.	O

Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
is	O
most	O
often	O
caused	O
by	O
anti-D	O
but	O
may	O
also	O
occur	O
due	O
to	O
anti-K	O
,	O
-c	B:C0432626
-	O
or	O
-	O
E	I:C0947659
.	O

Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
is	O
most	O
often	O
caused	O
by	O
anti-D	O
but	O
may	O
also	O
occur	O
due	O
to	O
anti-K	O
,	O
-c	O
-	O
or	O
-	B:C0947659
E	I:C0947659
.	O

We	O
recently	O
found	O
N	B:C1622430
-	I:C1622430
linked	I:C1622430
glycosylation	I:C1622430
of	O
anti-D	O
to	O
be	O
skewed	O
towards	O
low	O
fucosylation	O
,	O
thereby	O
increasing	O
the	O
affinity	O
to	O
IgG	O
-	I:C1521898
Fc	I:C1521898
receptor	I:C1521898
IIIa	I:C1521898
and	O
IIIb	O
,	O
which	O
correlated	O
with	O
Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
disease	O
severity	O
.	O

We	O
recently	O
found	O
N	O
-	I:C1622430
linked	I:C1622430
glycosylation	I:C1622430
of	O
anti-D	B:C0140430
to	O
be	O
skewed	O
towards	O
low	O
fucosylation	O
,	O
thereby	O
increasing	O
the	O
affinity	O
to	O
IgG	O
-	I:C1521898
Fc	I:C1521898
receptor	I:C1521898
IIIa	I:C1521898
and	O
IIIb	O
,	O
which	O
correlated	O
with	O
Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
disease	O
severity	O
.	O

We	O
recently	O
found	O
N	O
-	I:C1622430
linked	I:C1622430
glycosylation	I:C1622430
of	O
anti-D	O
to	O
be	O
skewed	O
towards	O
low	O
fucosylation	B:C3271553
,	O
thereby	O
increasing	O
the	O
affinity	O
to	O
IgG	O
-	I:C1521898
Fc	I:C1521898
receptor	I:C1521898
IIIa	I:C1521898
and	O
IIIb	O
,	O
which	O
correlated	O
with	O
Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
disease	O
severity	O
.	O

We	O
recently	O
found	O
N	O
-	I:C1622430
linked	I:C1622430
glycosylation	I:C1622430
of	O
anti-D	O
to	O
be	O
skewed	O
towards	O
low	O
fucosylation	O
,	O
thereby	O
increasing	O
the	O
affinity	B:C0003255
to	O
IgG	O
-	I:C1521898
Fc	I:C1521898
receptor	I:C1521898
IIIa	I:C1521898
and	O
IIIb	O
,	O
which	O
correlated	O
with	O
Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
disease	O
severity	O
.	O

We	O
recently	O
found	O
N	O
-	I:C1622430
linked	I:C1622430
glycosylation	I:C1622430
of	O
anti-D	O
to	O
be	O
skewed	O
towards	O
low	O
fucosylation	O
,	O
thereby	O
increasing	O
the	O
affinity	O
to	O
IgG	B:C1521898
-	I:C1521898
Fc	I:C1521898
receptor	I:C1521898
IIIa	I:C1521898
and	O
IIIb	O
,	O
which	O
correlated	O
with	O
Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
disease	O
severity	O
.	O

We	O
recently	O
found	O
N	O
-	I:C1622430
linked	I:C1622430
glycosylation	I:C1622430
of	O
anti-D	O
to	O
be	O
skewed	O
towards	O
low	O
fucosylation	O
,	O
thereby	O
increasing	O
the	O
affinity	O
to	O
IgG	O
-	I:C1521898
Fc	I:C1521898
receptor	I:C1521898
IIIa	I:C1521898
and	O
IIIb	B:C0966831
,	O
which	O
correlated	O
with	O
Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
disease	O
severity	O
.	O

We	O
recently	O
found	O
N	O
-	I:C1622430
linked	I:C1622430
glycosylation	I:C1622430
of	O
anti-D	O
to	O
be	O
skewed	O
towards	O
low	O
fucosylation	O
,	O
thereby	O
increasing	O
the	O
affinity	O
to	O
IgG	O
-	I:C1521898
Fc	I:C1521898
receptor	I:C1521898
IIIa	I:C1521898
and	O
IIIb	O
,	O
which	O
correlated	O
with	O
Haemolytic	B:C0014761
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
disease	O
severity	O
.	O

We	O
recently	O
found	O
N	O
-	I:C1622430
linked	I:C1622430
glycosylation	I:C1622430
of	O
anti-D	O
to	O
be	O
skewed	O
towards	O
low	O
fucosylation	O
,	O
thereby	O
increasing	O
the	O
affinity	O
to	O
IgG	O
-	I:C1521898
Fc	I:C1521898
receptor	I:C1521898
IIIa	I:C1521898
and	O
IIIb	O
,	O
which	O
correlated	O
with	O
Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
disease	B:C0012634
severity	O
.	O

Here	O
,	O
we	O
analysed	O
230	O
pregnant	B:C0033011
women	I:C0033011
with	O
anti-c	O
,	O
-	O
E	I:C0947659
or	O
-K	O
alloantibodies	O
from	O
a	O
prospective	O
screening	O
cohort	I:C0422390
and	O
investigated	O
the	O
type	O
of	O
Fc-tail	O
glycosylation	I:C0376322
of	O
these	O
antibodies	O
in	O
relation	O
to	O
the	O
trigger	O
of	O
immunisation	O
and	O
pregnancy	O
outcome	I:C0032972
.	O

Here	O
,	O
we	O
analysed	O
230	O
pregnant	O
women	I:C0033011
with	O
anti-c	B:C0432626
,	O
-	O
E	I:C0947659
or	O
-K	O
alloantibodies	O
from	O
a	O
prospective	O
screening	O
cohort	I:C0422390
and	O
investigated	O
the	O
type	O
of	O
Fc-tail	O
glycosylation	I:C0376322
of	O
these	O
antibodies	O
in	O
relation	O
to	O
the	O
trigger	O
of	O
immunisation	O
and	O
pregnancy	O
outcome	I:C0032972
.	O

Here	O
,	O
we	O
analysed	O
230	O
pregnant	O
women	I:C0033011
with	O
anti-c	O
,	O
-	B:C0947659
E	I:C0947659
or	O
-K	O
alloantibodies	O
from	O
a	O
prospective	O
screening	O
cohort	I:C0422390
and	O
investigated	O
the	O
type	O
of	O
Fc-tail	O
glycosylation	I:C0376322
of	O
these	O
antibodies	O
in	O
relation	O
to	O
the	O
trigger	O
of	O
immunisation	O
and	O
pregnancy	O
outcome	I:C0032972
.	O

Here	O
,	O
we	O
analysed	O
230	O
pregnant	O
women	I:C0033011
with	O
anti-c	O
,	O
-	O
E	I:C0947659
or	O
-K	B:C0313239
alloantibodies	O
from	O
a	O
prospective	O
screening	O
cohort	I:C0422390
and	O
investigated	O
the	O
type	O
of	O
Fc-tail	O
glycosylation	I:C0376322
of	O
these	O
antibodies	O
in	O
relation	O
to	O
the	O
trigger	O
of	O
immunisation	O
and	O
pregnancy	O
outcome	I:C0032972
.	O

Here	O
,	O
we	O
analysed	O
230	O
pregnant	O
women	I:C0033011
with	O
anti-c	O
,	O
-	O
E	I:C0947659
or	O
-K	O
alloantibodies	B:C0022144
from	O
a	O
prospective	O
screening	O
cohort	I:C0422390
and	O
investigated	O
the	O
type	O
of	O
Fc-tail	O
glycosylation	I:C0376322
of	O
these	O
antibodies	O
in	O
relation	O
to	O
the	O
trigger	O
of	O
immunisation	O
and	O
pregnancy	O
outcome	I:C0032972
.	O

Here	O
,	O
we	O
analysed	O
230	O
pregnant	O
women	I:C0033011
with	O
anti-c	O
,	O
-	O
E	I:C0947659
or	O
-K	O
alloantibodies	O
from	O
a	O
prospective	O
screening	B:C0422390
cohort	I:C0422390
and	O
investigated	O
the	O
type	O
of	O
Fc-tail	O
glycosylation	I:C0376322
of	O
these	O
antibodies	O
in	O
relation	O
to	O
the	O
trigger	O
of	O
immunisation	O
and	O
pregnancy	O
outcome	I:C0032972
.	O

Here	O
,	O
we	O
analysed	O
230	O
pregnant	O
women	I:C0033011
with	O
anti-c	O
,	O
-	O
E	I:C0947659
or	O
-K	O
alloantibodies	O
from	O
a	O
prospective	O
screening	O
cohort	I:C0422390
and	O
investigated	O
the	O
type	O
of	O
Fc-tail	B:C0376322
glycosylation	I:C0376322
of	O
these	O
antibodies	O
in	O
relation	O
to	O
the	O
trigger	O
of	O
immunisation	O
and	O
pregnancy	O
outcome	I:C0032972
.	O

Here	O
,	O
we	O
analysed	O
230	O
pregnant	O
women	I:C0033011
with	O
anti-c	O
,	O
-	O
E	I:C0947659
or	O
-K	O
alloantibodies	O
from	O
a	O
prospective	O
screening	O
cohort	I:C0422390
and	O
investigated	O
the	O
type	O
of	O
Fc-tail	O
glycosylation	I:C0376322
of	O
these	O
antibodies	B:C0003241
in	O
relation	O
to	O
the	O
trigger	O
of	O
immunisation	O
and	O
pregnancy	O
outcome	I:C0032972
.	O

Here	O
,	O
we	O
analysed	O
230	O
pregnant	O
women	I:C0033011
with	O
anti-c	O
,	O
-	O
E	I:C0947659
or	O
-K	O
alloantibodies	O
from	O
a	O
prospective	O
screening	O
cohort	I:C0422390
and	O
investigated	O
the	O
type	O
of	O
Fc-tail	O
glycosylation	I:C0376322
of	O
these	O
antibodies	O
in	O
relation	O
to	O
the	O
trigger	O
of	O
immunisation	B:C0020971
and	O
pregnancy	O
outcome	I:C0032972
.	O

Here	O
,	O
we	O
analysed	O
230	O
pregnant	O
women	I:C0033011
with	O
anti-c	O
,	O
-	O
E	I:C0947659
or	O
-K	O
alloantibodies	O
from	O
a	O
prospective	O
screening	O
cohort	I:C0422390
and	O
investigated	O
the	O
type	O
of	O
Fc-tail	O
glycosylation	I:C0376322
of	O
these	O
antibodies	O
in	O
relation	O
to	O
the	O
trigger	O
of	O
immunisation	O
and	O
pregnancy	B:C0032972
outcome	I:C0032972
.	O

Anti-c	B:C0432626
,	O
-E	O
and	O
-K	O
show	O
-	O
independent	O
of	O
the	O
event	O
that	O
had	O
led	O
to	O
immunisation	O
-	O
a	O
different	O
kind	O
of	O
Fc	O
-	I:C0376322
glycosylation	I:C0376322
compared	O
to	O
that	O
of	O
the	O
total	O
IgG	O
fraction	I:C0020852
,	O
but	O
with	O
less	O
pronounced	O
differences	O
compared	O
to	O
anti-D.	O
High	O
Fc	O
-	I:C1159287
galactosylation	I:C1159287
and	O
sialylation	O
of	O
anti-c	O
correlated	O
with	O
Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
disease	O
severity	O
,	O
while	O
low	O
anti-K	O
Fc-	O
fucosylation	I:C1159287
correlated	O
with	O
severe	O
fetal	O
anaemia	I:C2349595
.	O

Anti-c	O
,	O
-E	B:C0947659
and	O
-K	O
show	O
-	O
independent	O
of	O
the	O
event	O
that	O
had	O
led	O
to	O
immunisation	O
-	O
a	O
different	O
kind	O
of	O
Fc	O
-	I:C0376322
glycosylation	I:C0376322
compared	O
to	O
that	O
of	O
the	O
total	O
IgG	O
fraction	I:C0020852
,	O
but	O
with	O
less	O
pronounced	O
differences	O
compared	O
to	O
anti-D.	O
High	O
Fc	O
-	I:C1159287
galactosylation	I:C1159287
and	O
sialylation	O
of	O
anti-c	O
correlated	O
with	O
Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
disease	O
severity	O
,	O
while	O
low	O
anti-K	O
Fc-	O
fucosylation	I:C1159287
correlated	O
with	O
severe	O
fetal	O
anaemia	I:C2349595
.	O

Anti-c	O
,	O
-E	O
and	O
-K	B:C0313239
show	O
-	O
independent	O
of	O
the	O
event	O
that	O
had	O
led	O
to	O
immunisation	O
-	O
a	O
different	O
kind	O
of	O
Fc	O
-	I:C0376322
glycosylation	I:C0376322
compared	O
to	O
that	O
of	O
the	O
total	O
IgG	O
fraction	I:C0020852
,	O
but	O
with	O
less	O
pronounced	O
differences	O
compared	O
to	O
anti-D.	O
High	O
Fc	O
-	I:C1159287
galactosylation	I:C1159287
and	O
sialylation	O
of	O
anti-c	O
correlated	O
with	O
Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
disease	O
severity	O
,	O
while	O
low	O
anti-K	O
Fc-	O
fucosylation	I:C1159287
correlated	O
with	O
severe	O
fetal	O
anaemia	I:C2349595
.	O

Anti-c	O
,	O
-E	O
and	O
-K	O
show	O
-	O
independent	O
of	O
the	O
event	O
that	O
had	O
led	O
to	O
immunisation	B:C0020971
-	O
a	O
different	O
kind	O
of	O
Fc	O
-	I:C0376322
glycosylation	I:C0376322
compared	O
to	O
that	O
of	O
the	O
total	O
IgG	O
fraction	I:C0020852
,	O
but	O
with	O
less	O
pronounced	O
differences	O
compared	O
to	O
anti-D.	O
High	O
Fc	O
-	I:C1159287
galactosylation	I:C1159287
and	O
sialylation	O
of	O
anti-c	O
correlated	O
with	O
Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
disease	O
severity	O
,	O
while	O
low	O
anti-K	O
Fc-	O
fucosylation	I:C1159287
correlated	O
with	O
severe	O
fetal	O
anaemia	I:C2349595
.	O

Anti-c	O
,	O
-E	O
and	O
-K	O
show	O
-	O
independent	O
of	O
the	O
event	O
that	O
had	O
led	O
to	O
immunisation	O
-	O
a	O
different	O
kind	O
of	O
Fc	B:C0376322
-	I:C0376322
glycosylation	I:C0376322
compared	O
to	O
that	O
of	O
the	O
total	O
IgG	O
fraction	I:C0020852
,	O
but	O
with	O
less	O
pronounced	O
differences	O
compared	O
to	O
anti-D.	O
High	O
Fc	O
-	I:C1159287
galactosylation	I:C1159287
and	O
sialylation	O
of	O
anti-c	O
correlated	O
with	O
Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
disease	O
severity	O
,	O
while	O
low	O
anti-K	O
Fc-	O
fucosylation	I:C1159287
correlated	O
with	O
severe	O
fetal	O
anaemia	I:C2349595
.	O

Anti-c	O
,	O
-E	O
and	O
-K	O
show	O
-	O
independent	O
of	O
the	O
event	O
that	O
had	O
led	O
to	O
immunisation	O
-	O
a	O
different	O
kind	O
of	O
Fc	O
-	I:C0376322
glycosylation	I:C0376322
compared	O
to	O
that	O
of	O
the	O
total	O
IgG	B:C0020852
fraction	I:C0020852
,	O
but	O
with	O
less	O
pronounced	O
differences	O
compared	O
to	O
anti-D.	O
High	O
Fc	O
-	I:C1159287
galactosylation	I:C1159287
and	O
sialylation	O
of	O
anti-c	O
correlated	O
with	O
Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
disease	O
severity	O
,	O
while	O
low	O
anti-K	O
Fc-	O
fucosylation	I:C1159287
correlated	O
with	O
severe	O
fetal	O
anaemia	I:C2349595
.	O

Anti-c	O
,	O
-E	O
and	O
-K	O
show	O
-	O
independent	O
of	O
the	O
event	O
that	O
had	O
led	O
to	O
immunisation	O
-	O
a	O
different	O
kind	O
of	O
Fc	O
-	I:C0376322
glycosylation	I:C0376322
compared	O
to	O
that	O
of	O
the	O
total	O
IgG	O
fraction	I:C0020852
,	O
but	O
with	O
less	O
pronounced	O
differences	O
compared	O
to	O
anti-D.	B:C0140430
High	O
Fc	O
-	I:C1159287
galactosylation	I:C1159287
and	O
sialylation	O
of	O
anti-c	O
correlated	O
with	O
Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
disease	O
severity	O
,	O
while	O
low	O
anti-K	O
Fc-	O
fucosylation	I:C1159287
correlated	O
with	O
severe	O
fetal	O
anaemia	I:C2349595
.	O

Anti-c	O
,	O
-E	O
and	O
-K	O
show	O
-	O
independent	O
of	O
the	O
event	O
that	O
had	O
led	O
to	O
immunisation	O
-	O
a	O
different	O
kind	O
of	O
Fc	O
-	I:C0376322
glycosylation	I:C0376322
compared	O
to	O
that	O
of	O
the	O
total	O
IgG	O
fraction	I:C0020852
,	O
but	O
with	O
less	O
pronounced	O
differences	O
compared	O
to	O
anti-D.	O
High	O
Fc	B:C1159287
-	I:C1159287
galactosylation	I:C1159287
and	O
sialylation	O
of	O
anti-c	O
correlated	O
with	O
Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
disease	O
severity	O
,	O
while	O
low	O
anti-K	O
Fc-	O
fucosylation	I:C1159287
correlated	O
with	O
severe	O
fetal	O
anaemia	I:C2349595
.	O

Anti-c	O
,	O
-E	O
and	O
-K	O
show	O
-	O
independent	O
of	O
the	O
event	O
that	O
had	O
led	O
to	O
immunisation	O
-	O
a	O
different	O
kind	O
of	O
Fc	O
-	I:C0376322
glycosylation	I:C0376322
compared	O
to	O
that	O
of	O
the	O
total	O
IgG	O
fraction	I:C0020852
,	O
but	O
with	O
less	O
pronounced	O
differences	O
compared	O
to	O
anti-D.	O
High	O
Fc	O
-	I:C1159287
galactosylation	I:C1159287
and	O
sialylation	B:C4235385
of	O
anti-c	O
correlated	O
with	O
Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
disease	O
severity	O
,	O
while	O
low	O
anti-K	O
Fc-	O
fucosylation	I:C1159287
correlated	O
with	O
severe	O
fetal	O
anaemia	I:C2349595
.	O

Anti-c	O
,	O
-E	O
and	O
-K	O
show	O
-	O
independent	O
of	O
the	O
event	O
that	O
had	O
led	O
to	O
immunisation	O
-	O
a	O
different	O
kind	O
of	O
Fc	O
-	I:C0376322
glycosylation	I:C0376322
compared	O
to	O
that	O
of	O
the	O
total	O
IgG	O
fraction	I:C0020852
,	O
but	O
with	O
less	O
pronounced	O
differences	O
compared	O
to	O
anti-D.	O
High	O
Fc	O
-	I:C1159287
galactosylation	I:C1159287
and	O
sialylation	O
of	O
anti-c	B:C0432626
correlated	O
with	O
Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
disease	O
severity	O
,	O
while	O
low	O
anti-K	O
Fc-	O
fucosylation	I:C1159287
correlated	O
with	O
severe	O
fetal	O
anaemia	I:C2349595
.	O

Anti-c	O
,	O
-E	O
and	O
-K	O
show	O
-	O
independent	O
of	O
the	O
event	O
that	O
had	O
led	O
to	O
immunisation	O
-	O
a	O
different	O
kind	O
of	O
Fc	O
-	I:C0376322
glycosylation	I:C0376322
compared	O
to	O
that	O
of	O
the	O
total	O
IgG	O
fraction	I:C0020852
,	O
but	O
with	O
less	O
pronounced	O
differences	O
compared	O
to	O
anti-D.	O
High	O
Fc	O
-	I:C1159287
galactosylation	I:C1159287
and	O
sialylation	O
of	O
anti-c	O
correlated	O
with	O
Haemolytic	B:C0014761
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
disease	O
severity	O
,	O
while	O
low	O
anti-K	O
Fc-	O
fucosylation	I:C1159287
correlated	O
with	O
severe	O
fetal	O
anaemia	I:C2349595
.	O

Anti-c	O
,	O
-E	O
and	O
-K	O
show	O
-	O
independent	O
of	O
the	O
event	O
that	O
had	O
led	O
to	O
immunisation	O
-	O
a	O
different	O
kind	O
of	O
Fc	O
-	I:C0376322
glycosylation	I:C0376322
compared	O
to	O
that	O
of	O
the	O
total	O
IgG	O
fraction	I:C0020852
,	O
but	O
with	O
less	O
pronounced	O
differences	O
compared	O
to	O
anti-D.	O
High	O
Fc	O
-	I:C1159287
galactosylation	I:C1159287
and	O
sialylation	O
of	O
anti-c	O
correlated	O
with	O
Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
disease	B:C0012634
severity	O
,	O
while	O
low	O
anti-K	O
Fc-	O
fucosylation	I:C1159287
correlated	O
with	O
severe	O
fetal	O
anaemia	I:C2349595
.	O

Anti-c	O
,	O
-E	O
and	O
-K	O
show	O
-	O
independent	O
of	O
the	O
event	O
that	O
had	O
led	O
to	O
immunisation	O
-	O
a	O
different	O
kind	O
of	O
Fc	O
-	I:C0376322
glycosylation	I:C0376322
compared	O
to	O
that	O
of	O
the	O
total	O
IgG	O
fraction	I:C0020852
,	O
but	O
with	O
less	O
pronounced	O
differences	O
compared	O
to	O
anti-D.	O
High	O
Fc	O
-	I:C1159287
galactosylation	I:C1159287
and	O
sialylation	O
of	O
anti-c	O
correlated	O
with	O
Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
disease	O
severity	O
,	O
while	O
low	O
anti-K	B:C0313239
Fc-	O
fucosylation	I:C1159287
correlated	O
with	O
severe	O
fetal	O
anaemia	I:C2349595
.	O

Anti-c	O
,	O
-E	O
and	O
-K	O
show	O
-	O
independent	O
of	O
the	O
event	O
that	O
had	O
led	O
to	O
immunisation	O
-	O
a	O
different	O
kind	O
of	O
Fc	O
-	I:C0376322
glycosylation	I:C0376322
compared	O
to	O
that	O
of	O
the	O
total	O
IgG	O
fraction	I:C0020852
,	O
but	O
with	O
less	O
pronounced	O
differences	O
compared	O
to	O
anti-D.	O
High	O
Fc	O
-	I:C1159287
galactosylation	I:C1159287
and	O
sialylation	O
of	O
anti-c	O
correlated	O
with	O
Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
disease	O
severity	O
,	O
while	O
low	O
anti-K	O
Fc-	B:C1159287
fucosylation	I:C1159287
correlated	O
with	O
severe	O
fetal	O
anaemia	I:C2349595
.	O

Anti-c	O
,	O
-E	O
and	O
-K	O
show	O
-	O
independent	O
of	O
the	O
event	O
that	O
had	O
led	O
to	O
immunisation	O
-	O
a	O
different	O
kind	O
of	O
Fc	O
-	I:C0376322
glycosylation	I:C0376322
compared	O
to	O
that	O
of	O
the	O
total	O
IgG	O
fraction	I:C0020852
,	O
but	O
with	O
less	O
pronounced	O
differences	O
compared	O
to	O
anti-D.	O
High	O
Fc	O
-	I:C1159287
galactosylation	I:C1159287
and	O
sialylation	O
of	O
anti-c	O
correlated	O
with	O
Haemolytic	O
disease	I:C0014761
of	I:C0014761
the	I:C0014761
fetus	I:C0014761
and	I:C0014761
newborn	I:C0014761
disease	O
severity	O
,	O
while	O
low	O
anti-K	O
Fc-	O
fucosylation	I:C1159287
correlated	O
with	O
severe	O
fetal	B:C2349595
anaemia	I:C2349595
.	O

IgG	B:C0376322
-	I:C0376322
Fc	I:C0376322
glycosylation	I:C0376322
of	O
anti-RBC	O
antibodies	I:C0003241
is	O
shaped	O
depending	O
on	O
the	O
antigen	O
.	O

IgG	O
-	I:C0376322
Fc	I:C0376322
glycosylation	I:C0376322
of	O
anti-RBC	B:C0003241
antibodies	I:C0003241
is	O
shaped	O
depending	O
on	O
the	O
antigen	O
.	O

IgG	O
-	I:C0376322
Fc	I:C0376322
glycosylation	I:C0376322
of	O
anti-RBC	O
antibodies	I:C0003241
is	O
shaped	O
depending	O
on	O
the	O
antigen	B:C0003320
.	O

